跳至主要内容
临床试验/NCT05164289
NCT05164289终止不适用

Interest of EMDR (Eye Movement Desensitization and Reprocessing) Psychotherapy in the Management of Schizophrenic Disorders

Hôpital NOVO2 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2021年12月10日最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
6
试验地点
2
主要终点
Assessment of the decrease in the severity of positive or negative symptoms of schizophrenia

研究概览

简要总结

The purpose of this study is to determine the interest of the use of EMDR (Eye Movement Desensitization and Reprocessing) psychotherapy in the management of psychotic disorders, in particular schizophrenic disorders.

详细描述

Since 2015 more and more studies conducted by researchers, especially Dutch and English, are interested in the use of EMDR (Eye Movement Desensitization and Reprocessing) for other pathologies such as bipolar disorder, unipolar depression, anxiety disorders, psychotic disorders, substance use disorders and chronic pain.

These studies show that EMDR appears to be a technique that is both effective, capable of significantly improving symptoms, and without risk for patients, while respecting the protocol and the clinical stabilization provided during the procedure.

To date, the use of EMDR for the management of psychotic patients has not been the subject of any prospective study in France and the authors' conclusions converge on the fact that it is essential to carry out more research on the subject.

For this, the investigators wish to evaluate the effect of EMDR on the management of patients with schizophrenic disorders, on the basis that this psychotherapy would improve their quality of life (improvement of all the specific scores used in psychiatry). : PANSS, DES, HAD and WEMWBS scales).

Finally, the investigators believe that it is relevant to assess the benefit of EMDR six months after hospitalization of patients, in order to measure the maintenance of this efficacy in the medium term

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • ≥ 18 years and over,
  • Hospitalized for decompensated psychotic disorder, Positive diagnosis of schizophrenia or schizoaffective disorder (according to the DSM-V psychiatry manual),
  • With positive or negative symptoms according to the Positive and Negative Syndrome Scale (PANSS),
  • Stabilized clinical condition (considered compatible with hospital discharge),
  • With ambulatory follow-up planned after hospitalization

排除标准

  • < 18 years,
  • Patients who do not meet the diagnostic criteria (according to the DSM-V psychiatry manual) for schizophrenic or schizoaffective disorder),
  • Non-French speaking or illiterate patients,
  • Cognitive disorders making it impossible the understanding and the none- opposition to the study,
  • Non-stabilized clinical condition (incompatible with hospital discharge),

结局指标

主要结局

Assessment of the decrease in the severity of positive or negative symptoms of schizophrenia

时间窗: At 6 month after Hospital discharge (M0)

The decrease in the severity of positive or negative symptoms of schizophrenia is assessed using the "Positive and Negative Syndrome Scale" (PANSS) between M0 and M6.This decrease will be considered effective if it's greater than or equal to 20%.

次要结局

  • Assessment of the decrease in the intensity of anxiety and depressive symptoms.(At 6 month after Hospital discharge (M0))
  • Assessment of the decrease in the intensity of dissociative symptoms.(At 6 month after Hospital discharge (M0))
  • Quality of life assessment(At 6 month after Hospital discharge (M0))

研究者

发起方
Hôpital NOVO
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Interest of EMDR Schizophrenic Disorders | 临床试验